drugset / Trial / NCT05603182
A Study of PRA052 in Healthy Volunteers
RandomizedSequentialDouble-blindOther
Summary
This is randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PRA052 in healthy volunteers.
Timeline
- Start
- 2022-11-07
- Primary completion
- 2024-02-21
- Completion
- 2024-02-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PRA052 | Unknown | — | Intravenous |
Indications
No indication recorded.